Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

about

Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis

P2860

Q58762933-5AE6EDF1-180A-43F7-A8DE-BEFE32DDC06B

P2860

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

Item

http://www.wikidata.org/entity/Q42283696

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

@en

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

@nl

type

Item

label

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

@en

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

@nl

prefLabel

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

@en

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

@nl

P1476

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

@en

P2093

Fu-Xian Zhang

http://www.w3.org/2001/XMLSchema#string

Hai-Bing Ju

http://www.w3.org/2001/XMLSchema#string

Hai-Yan Zhang

http://www.w3.org/2001/XMLSchema#string

Jie Song

http://www.w3.org/2001/XMLSchema#string

Li-Feng Li

http://www.w3.org/2001/XMLSchema#string

Shuang Wang

http://www.w3.org/2001/XMLSchema#string

Tao Cui

http://www.w3.org/2001/XMLSchema#string

P2860

Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications

Fenofibrate - a potential systemic treatment for diabetic retinopathy?

Fenofibrate and Diabetic Retinopathy.

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate.

Roles of elevated intravitreal IL-1β and IL-10 levels in proliferative diabetic retinopathy

Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy

The involvement of high mobility group 1 cytokine and phospholipases A2 in diabetic retinopathy.

An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes

The use of fenofibrate in the management of patients with diabetic retinopathy: an evidence-based review.

P304

e7671

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000007671

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28767589

http://www.w3.org/2001/XMLSchema#string

P932

5626143

http://www.w3.org/2001/XMLSchema#string

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

about

P2860

P2860

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932